[go: up one dir, main page]

AU2003294762A1 - Film-type preparations for transmucosal administration of nicotine and method for the production thereof - Google Patents

Film-type preparations for transmucosal administration of nicotine and method for the production thereof

Info

Publication number
AU2003294762A1
AU2003294762A1 AU2003294762A AU2003294762A AU2003294762A1 AU 2003294762 A1 AU2003294762 A1 AU 2003294762A1 AU 2003294762 A AU2003294762 A AU 2003294762A AU 2003294762 A AU2003294762 A AU 2003294762A AU 2003294762 A1 AU2003294762 A1 AU 2003294762A1
Authority
AU
Australia
Prior art keywords
nicotine
film
production
transmucosal administration
type preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003294762A
Inventor
Markus Krumme
Frank Seibertz
Christian Von Falkenhausen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU2003294762A1 publication Critical patent/AU2003294762A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003294762A 2002-12-05 2003-12-02 Film-type preparations for transmucosal administration of nicotine and method for the production thereof Abandoned AU2003294762A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10256775A DE10256775A1 (en) 2002-12-05 2002-12-05 Preparation of film forming composition for transmucosal delivery of nicotine used for treating tobacco addiction, includes converting nicotine free base to its salt with acid and/or incorporation of nicotine as salt
DE10256775.1 2002-12-05
PCT/EP2003/013536 WO2004054551A1 (en) 2002-12-05 2003-12-02 Film-type preparations for transmucosal administration of nicotine and method for the production thereof

Publications (1)

Publication Number Publication Date
AU2003294762A1 true AU2003294762A1 (en) 2004-07-09

Family

ID=32335983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003294762A Abandoned AU2003294762A1 (en) 2002-12-05 2003-12-02 Film-type preparations for transmucosal administration of nicotine and method for the production thereof

Country Status (5)

Country Link
AR (1) AR042307A1 (en)
AU (1) AU2003294762A1 (en)
DE (1) DE10256775A1 (en)
TW (1) TW200413035A (en)
WO (1) WO2004054551A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0302947D0 (en) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
US20040234914A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
MXPA06000852A (en) 2003-07-24 2006-03-30 Smithkline Beecham Corp Orally dissolving films.
EP1781360A1 (en) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
DE102005007859A1 (en) * 2005-02-21 2006-08-24 Lts Lohmann Therapie-Systeme Ag Procedures for a combination drug treatment, as well as suitable drug combinations
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
AU2007214474B2 (en) 2006-02-17 2011-01-20 Novartis Ag Disintegrable oral films
DE102006027795A1 (en) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Smoking cessation combination wafer
EP2248519B1 (en) * 2006-10-02 2017-12-06 Apr Applied Pharma Research S.A. Non-mucoadhesive film dosage forms
JP5784878B2 (en) * 2007-03-07 2015-09-24 ノバルティス アーゲー Orally administrable film
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
CN106290605B (en) * 2016-07-22 2018-06-12 云南中烟工业有限责任公司 One assay method for growing tobacco middle sesquiterpenoids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646392A1 (en) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US20010016593A1 (en) * 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
DE10018834A1 (en) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermal or transmucosal pharmaceutical dosage form for treatment of nicotine dependence or smoking withdrawal contains nicotine compound or substitute and CNS active compound
DE10032456A1 (en) * 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Rapidly disintegrating dosage form for the release of active substances in the mouth or in the body cavities
NZ530439A (en) * 2001-04-20 2004-11-26 Lavipharm Lab Inc Intraoral delivery of nicotine for smoking cessation
JP5089840B2 (en) * 2001-09-25 2012-12-05 救急薬品工業株式会社 Nicotine-containing film preparation

Also Published As

Publication number Publication date
DE10256775A1 (en) 2004-06-24
WO2004054551A1 (en) 2004-07-01
AR042307A1 (en) 2005-06-15
TW200413035A (en) 2004-08-01

Similar Documents

Publication Publication Date Title
AU2003211376A1 (en) Drug administration method
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
AU2002344151A1 (en) Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
IL163831A0 (en) Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing
AU2001240753A1 (en) Lipid nanocapsules, preparation method and use as medicine
AU6271401A (en) Drug administering system and administering method
AU2001278849A1 (en) Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives
WO2001010816A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
AU2001270778A1 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
AU2003294762A1 (en) Film-type preparations for transmucosal administration of nicotine and method for the production thereof
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
AU2001263835A1 (en) Haemostatically active preparation containing vWF and method for the production thereof
AU2002329311A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
AU2002366799A1 (en) Allantoin-containing preparations for administration as gels and aerosols
AU2003286944A1 (en) Crude drug compositions and the process for preparing them
PL359208A1 (en) New derivatives of quinosoline, method of production of new derivatives of quinosoline and pharmaceutical preparations
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU2003246840A1 (en) Anti-hiv composition, production method thereof and medicament
AU2002333449A1 (en) C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
AU2003289566A1 (en) Preparation method of 1,5-dimethyltetralin
AU2003245057A1 (en) 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase